Tg(KRT14-MAP2K1/Esr1)12Pkha
Transgene Detail
|
Symbol: |
Tg(KRT14-MAP2K1/Esr1)12Pkha |
Name: |
transgene insertion 12, Paul A Khavari |
MGI ID: |
MGI:3700387 |
Synonyms: |
CA-Mek1:ER, CA-Mek1:ER (line 12), K14-Mek1:ER (line 12), M1E-12, Mek1:ER |
Transgene: |
Tg(KRT14-MAP2K1/Esr1)12Pkha Location: unknown
|
Alliance: |
Tg(KRT14-MAP2K1/Esr1)12Pkha page
|
|
|
Transgene Type: |
|
Transgenic (Constitutively active, Humanized sequence, Inducible, Inserted expressed sequence) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Tg(KRT14-MAP2K1/Esr1)12Pkha expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
MAP2K1 (5604) |
|
|
|
|
|
Mutation details: The transgene contains a 2075-bp human keratin 14 promoter construct with a 5' intron from a beta-globin gene driving expression of a cDNA that encodes a constitutively active mutant human mitogen activated protein kinase 1 (with deletion of amino acids 32-51, which comprise a putative alpha-helical domain, and the amino acid substitutions Ser218Glu and Ser222Asp, which remove phosphorylatively regulable serines). This is joined at its COOH-terminal with the Gly525Arg mutant ligand-binding domain of the mouse estrogen receptor (ERTM), which renders the fusion protein's activity inducible by 4-hydroxytamoxifen, but unresponsive to natural estrogen (17beta-estradiol).
(J:92407, J:118584, J:118587, J:118713, J:118714)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Of three PCR-confirmed transgenic mouse lines, two - designated lines 12 and 13 - express the fusion protein in skin. Topical tamoxifen treatment induces similar skin phenotypes in both lines that are more severe in line 12, which was therefore used in further studies.
|
Original: |
J:92407 Scholl FA, et al., Mek1 alters epidermal growth and differentiation. Cancer Res. 2004 Sep 1;64(17):6035-40 |
All: |
5 reference(s) |
|